Vera Therapeutics Inc. (NASDAQ: VERA) announced it has reached agreement with the U.S. Food and Drug Administration to accelerate the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA

Wolfe Research: 'VERA's continued weakness is creating a favorable setup into the July 7th PDUFA'June 2, 2026 12:28 PM